Subscribe To
Apple is going big on pricey goggles. 6 key takeaways.
Apple announced an augmented reality headset for a stunning $3,499—higher than most observers had exp...
June 6, 2023, 12:30 am
Eurozone april ppi -3.2% vs -3.1% m/m expected
Prior -1.6%; revised to -1.3%PPI +1.0% vs +1.4% y/y expectedPrior +5.9%; revised to +5.5%Looking at the details, the large chunk of the decline on the...
June 5, 2023, 9:00 am
Usdcad weekly analysis – june 4, 2023
The USDCAD currency pair has been exhibiting a period of consolidation, characterized by a sideways movement within a defined trading range. This rang...
June 4, 2023, 3:54 am
Apexigen announces phase 2 data evaluating sotigalimab, its cd40 agonist antibody, in combination with doxorubicin in patients with advanced soft tissue sarcoma presented at the american society of cl
– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstra...
June 3, 2023, 12:00 pm
Apexigen announces phase 2 data evaluating sotigalimab, its cd40 agonist antibody, in combination with doxorubicin in patients with advanced soft tissue sarcoma presented at the american society of cl
– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstra...
June 3, 2023, 12:00 pm
Apexigen announces phase 2 data evaluating sotigalimab, its cd40 agonist antibody, in combination with doxorubicin in patients with advanced soft tissue sarcoma presented at the american society of cl
– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstra...
June 3, 2023, 12:00 pm
Apexigen announces phase 2 data evaluating sotigalimab, its cd40 agonist antibody, in combination with doxorubicin in patients with advanced soft tissue sarcoma presented at the american society of cl
– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstra...
June 3, 2023, 12:00 pm
Apexigen announces phase 2 data evaluating sotigalimab, its cd40 agonist antibody, in combination with doxorubicin in patients with advanced soft tissue sarcoma presented at the american society of cl
– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstra...
June 3, 2023, 12:00 pm
Mohawk industries: continue to observe how margins improve
MHK shows promising signs of recovery with better-than-expected 1Q23 results, indicating a positive trend. Despite potential competition and pricing p...
June 2, 2023, 9:14 am
Treasury bonds: how this forecast is playing out
By Elliott Wave International The yield on U.S. Treasury bonds trended higher from 1942 to 1981 — that’s 39 years. Interestingly, yields (or inter...
June 1, 2023, 3:03 am
Bitcoin, crypto prices brace for downturn in coming liquidity shock, observers say
Improving liquidity conditions so far this year have lifted risk assets such as cryptocurrencies, but the trend is poised to turn once the U.S. debt c...
June 1, 2023, 12:44 am
Cftc warns derivatives clearinghouses against expansion into crypto
US derivatives regulator, the Commodities Futures Trading Commission (CFTC), has warned Derivatives Clearing Organizations (DCOs) against the risk inv...
May 30, 2023, 10:31 pm
Gold tea leaves could augur well for bitcoin
Gold and bitcoin are often viewed as two competing assets. In fact, some market observers view the cryp...
May 30, 2023, 11:35 am
Bank of america looks at the historical success rates of well-known technical indicators
Bank of America (BofA) has shared insights into 8technical strategies based on historical performance data, revealing a variety of potential investmen...
May 29, 2023, 5:18 pm
Bitcoin’s short-term holders are again selling at profit
Short-term holders’ renewed profitability is a positive signal for near-term price action, according to on o...
May 29, 2023, 10:29 am
U.s. weekly fundflows insight report: investors send $3.0 billion to investment-grade corp. debt funds, 7th weekly inflow in 8
Equity markets fell for the second straight session, led by the Russell 2000. Exchange-traded fixed-income funds ...
May 26, 2023, 12:13 am
Shattuck labs to present complete dose-escalation data from phase 1a monotherapy clinical trial of sl-172154 in platinum-resistant ovarian cancer (proc) at the american society of clinical oncology (a
– SL-172154 demonstrated favorable safety and tolerability profile across doses, with maximal CD47 and CD40 target engagement and CD40-dependent pha...
May 25, 2023, 9:15 pm
Shattuck labs to present complete dose-escalation data from phase 1a monotherapy clinical trial of sl-172154 in platinum-resistant ovarian cancer (proc) at the american society of clinical oncology (a
– SL-172154 demonstrated favorable safety and tolerability profile across doses, with maximal CD47 and CD40 target engagement and CD40-dependent pha...
May 25, 2023, 9:15 pm
Springworks therapeutics announces presentation of additional data from phase 3 defi trial of nirogacestat in adults with desmoid tumors at the 2023 asco annual meeting
– Nirogacestat Treatment Demonstrated Rapid, Sustained and Consistent Reductions in Pain Compared to Placebo Using Multiple Assessment Tools – –...
May 25, 2023, 9:05 pm
Updated linvoseltamab (bcmaxcd3) data from pivotal trial demonstrates early, deep and durable responses in patients with heavily pre-treated multiple myeloma
71% objective response rate, with 59% of patients achieving a very good partial response or better at the recommended 200 mg dose, per new data to be ...
May 25, 2023, 9:05 pm